Pricing & Market Access Strategy

Optimal uptake in the launch through smart pricing and contract design.

Increasing drug expenditure in the health care system has long been a key issue on the political agenda. The result is growing price pressure on pharmaceutical companies. A professionalized price and market access strategy along the entire product life cycle is becoming increasingly important. Homburg & Partner can help you find the optimal price for your product – from the price at launch to pricing in the inventory market.

Building on a comprehensive market analysis, the price readiness of various market participants is evaluated and translated into price recommendations. Our recommendations are always adapted to the needs of the respective reimbursement sector and the strategic objectives of the product. In order to enforce the identified prices on the market, we will also support you in designing a suitable contract strategy.

Our Pricing & Market Access Framework – the compass to implementing pricing strategies

Pricing & Market Access Framework

Our service portfolio in the area of Pricing & Market Access Strategy:

  • National price strategy (i.e. AMNOG, a German marketing law) and reference price effects
  • Sub-national price strategy (i.e. health insurance funds, hospital pharmacies)
  • Launch pricing (1 year prior to AMNOG)
  • Contract strategy and design
  • Value-added service strategy und -design
  • Stakeholder engagement & value communication
  • Price benchmarking

Our experts for the pharmaceutical sector

Partner

Christian Zuberer

christian.zuberer@homburg-partner.com
Tel.: +49 621 1582-212

Managing Director & Partner

Dr. Michael Scholl

michael.scholl@homburg-partner.com
Tel.: +49 621 1582-0